EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells

Irina O Petrova iD, Svetlana A Smirnikhina iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311466 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Irina O Petrova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye 1, 115478 Moscow, Russia. Hauptthemen laut MEDLINE: Genetic Therapy, Hematopoietic Stem Cells, Cell- and Tissue-Based Therapy, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of Russia, the Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ex vivo cell and gene therapy is a prospective approach to treatment of genetic diseases. To date, one of the most prevalent examples of genetically engineered cell therapies is hematopoietic stem/progenitor cells (HSPCs). This mini review is focused on HSPC therapy methods that have been approved for medical use. Most gene therapy methods rely on the lentiviral integration of the gene into the target cell genome, as lentiviruses are extremely effective, particularly in transduction of non-dividing cells. In this constantly evolving field, it is important to find the balance between safety concerns and efficiency. Analyzing cases of several diseases, for which ex vivo gene therapy was developed, we strive to understand which factors are crucial to success and what the potential drawbacks are. Although in general, viral gene integration demonstrates a considerable therapeutic effect, it has oncogenic potential. Development of self-inactivating vectors was a breakthrough in regard to safety, but the possibility of oncogenesis remains, and strict analysis of integration sites is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyHematopoietic Stem CellsCell- and Tissue-Based TherapyHematopoietic Stem Cell TransplantationHumansAnimalsGenetic VectorsLentivirus

Stichwörter der Autor:innen

CRISPR/Casgene therapyhematoietic stem/progenitor cellsviral vectors

Autor:innen und Institutionen

  • Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye 1, 115478 Moscow, Russia.

ORCID-Profile: Irina O Petrova, Svetlana A Smirnikhina

Förderung

  • Ministry of Education and Science of Russia
  • the Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Petrova, I. O., & Smirnikhina, S. A. (2025). Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311466

Vancouver

Petrova IO, Smirnikhina SA. Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311466

BibTeX
@article{Petrova2025,
  author = {Petrova, Irina O and Smirnikhina, Svetlana A},
  title = {Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311466}
}
Kostenlos starten →